80 related articles for article (PubMed ID: 18599112)
1. MVP expression is related to IGF1-R in cervical carcinoma patients treated by radiochemotherapy.
Lloret M; Lara PC; Bordón E; Rey A; Falcón O; Apolinario RM; Clavo B; Ruiz A
Gynecol Oncol; 2008 Sep; 110(3):304-7. PubMed ID: 18599112
[TBL] [Abstract][Full Text] [Related]
2. IGF-1R expression in localized cervical carcinoma patients treated by radiochemotherapy.
Lloret M; Lara PC; Bordón E; Pinar B; Rey A; Falcón O; Molano F; Hernández MA
Gynecol Oncol; 2007 Jul; 106(1):8-11. PubMed ID: 17490736
[TBL] [Abstract][Full Text] [Related]
3. BCL-2, in combination with MVP and IGF-1R expression, improves prediction of clinical outcome in complete response cervical carcinoma patients treated by radiochemotherapy.
Henríquez-Hernández LA; Lloret M; Pinar B; Bordón E; Rey A; Lubrano A; Lara PC
Gynecol Oncol; 2011 Sep; 122(3):585-9. PubMed ID: 21708403
[TBL] [Abstract][Full Text] [Related]
4. IGF-1R expression predicts clinical outcome in patients with locally advanced oral squamous cell carcinoma.
Lara PC; Bordón E; Rey A; Moreno M; Lloret M; Henríquez-Hernández LA
Oral Oncol; 2011 Jul; 47(7):615-9. PubMed ID: 21640634
[TBL] [Abstract][Full Text] [Related]
5. MVP expression in the prediction of clinical outcome of locally advanced oral squamous cell carcinoma patients treated with radiotherapy.
Henríquez-Hernández LA; Moreno M; Rey A; Lloret M; Lara PC
Radiat Oncol; 2012 Aug; 7():147. PubMed ID: 22931894
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
[TBL] [Abstract][Full Text] [Related]
7. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
8. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
Torbé B
Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
[TBL] [Abstract][Full Text] [Related]
9. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
Parker K; Gallop-Evans E; Hanna L; Adams M
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
[TBL] [Abstract][Full Text] [Related]
10. [Preoperative concomitant radiochemotherapy in bulky carcinoma of the cervix: Institut Curie experience].
Kirova YM; Bourhaleb Z; Alran S; Campitelli M; Plancher C; Fourchotte V; Beuzeboc P; Petrow P; Cottu P; de Cremoux P; Sastre-Garau X; de la Rochefordière A
Cancer Radiother; 2009 Jul; 13(4):291-7. PubMed ID: 19524469
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy.
Benavente S; Vergés R; Hermosilla E; Fumanal V; Casanova N; García A; Ramón Y Cajal S; Giralt J
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1316-22. PubMed ID: 19362787
[TBL] [Abstract][Full Text] [Related]
12. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
13. Tumor expression of major vault protein is an adverse prognostic factor for radiotherapy outcome in oropharyngeal carcinoma.
Silva P; West CM; Slevin N; Valentine H; Ryder WD; Hampson L; Bibi R; Sloan P; Thakker N; Homer J; Hampson I
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):133-40. PubMed ID: 17459603
[TBL] [Abstract][Full Text] [Related]
14. Expression of class III beta tubulin in cervical cancer patients administered preoperative radiochemotherapy: correlation with response to treatment and clinical outcome.
Ferrandina G; Martinelli E; Zannoni GF; Distefano M; Paglia A; Ferlini C; Scambia G
Gynecol Oncol; 2007 Feb; 104(2):326-30. PubMed ID: 17030352
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
Choi CH; Song SY; Choi JJ; Park YA; Kang H; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
BMC Cancer; 2008 Oct; 8():295. PubMed ID: 18847499
[TBL] [Abstract][Full Text] [Related]
16. Major vault protein may affect nonhomologous end-joining repair and apoptosis through Ku70/80 and bax downregulation in cervical carcinoma tumors.
Lloret M; Lara PC; Bordón E; Fontes F; Rey A; Pinar B; Falcón O
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):976-9. PubMed ID: 19251084
[TBL] [Abstract][Full Text] [Related]
17. Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? a twenty-year experience.
Jurado M; Alcázar JL; Martinez-Monge R
Gynecol Oncol; 2010 Jan; 116(1):38-43. PubMed ID: 19878978
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.
Kaneyasu Y; Nagai N; Nagata Y; Hashimoto Y; Yuki S; Murakami Y; Kenjo M; Kakizawa H; Toyota N; Fujiwara H; Kudo Y; Ito K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):369-77. PubMed ID: 19735865
[TBL] [Abstract][Full Text] [Related]
19. Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression.
Lara PC; Lloret M; Clavo B; Apolinario RM; Henríquez-Hernández LA; Bordón E; Fontes F; Rey A
Radiat Oncol; 2009 Aug; 4():29. PubMed ID: 19660100
[TBL] [Abstract][Full Text] [Related]
20. Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy.
Yeo SG; Kim JS; Cho MJ; Kim KH; Kim JS
Clin Cancer Res; 2009 Oct; 15(19):6201-7. PubMed ID: 19773374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
